503555-53-1

Basic information

• Product Name: 8-[(2,5-dichloroisonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
• Synonyms: 8-[(2,5-dichloroisonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
• CAS NO: 503555-53-1
• Molecular Weight: 496.328
• Mol File: 503555-53-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-[(2,5-dichloroisonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 8-[(2,5-dichloroisonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide(503555-53-1)
• EPA Substance Registry System: 8-[(2,5-dichloroisonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide(503555-53-1)

Safety Data

• Hazardous Substances Data: 503555-53-1(Hazardous Substances Data)

Upstream product

• 503555-51-9 C₁₈H₁₅FN₄O 
• 88912-26-9 2,5-dichloro-4-pyridinecarboxylic acid 

Downstream Products

• 503555-59-7 8-[(5-chloro-2-piperazin-1-ylisonicotinoyl)amino]-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-89-7 8-{[5-chloro-2-(1,4-diazepan-1-yl)isonicotinoyl]amino}-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623586-05-0 8-{[5-chloro-2-(4-ethylpiperazin-1-yl)isonicotinoyl]amino}-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 503555-58-6 8-{[5-chloro-2-(4-methyl-1,4-diazepan-1-yl)isonicotinoyl]-amino}-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623586-06-1 8-{[5-chloro-2-(4-isopropylpiperazin-1-yl)isonicotinoyl]-amino}-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-91-1 PHA-919 
• 623585-96-6 8-({5-chloro-2-[(3R,5S)-3,4,5-trimethylpiperazin-1-yl]-isonicotinoyl}amino)-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-99-9 8-({5-chloro-2-[(3R)-3,4-dimethylpiperazin-1-yl]isonicotinoyl}amino)-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623586-03-8 8-({5-chloro-2-[(3S)-3,4-dimethylpiperazin-1-yl]isonicotinoyl}amino)-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-93-3 8-({5-chloro-2-[(3R)-3-methylpiperazin-1-yl]isonicotinoyl}amino)-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-94-4 8-({5-chloro-2-[(3S)-3-methylpiperazin-1-yl]-isonicotinoyl}amino)-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 503555-60-0 8-({5-chloro-2-[[2-(dimethylamino)ethyl]-(methyl)amino]isonicotinoyl}amino)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-92-2 8-[(5-chloro-2-{[2-(dimethylamino)ethyl]amino}-isonicotinoyl)amino]-1-(4-fluoro-phenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 
• 623585-95-5 8-({5-chloro-2-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-isonicotinoyl}amino)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide 

Relevant articles and documents

Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship

Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and in IL-1β stimulated synovial fibroblasts. The 2-amino-5-chloropyridine-4-carboxamides were identified as the most potent inhibitors with im